Document is current

Any future updates will be listed below

When should Lenvatinib be switched to an alternative medication in patients with HCC who do not exhibit reactive blood pressure elevation?

Crossref DOI link: https://doi.org/10.1038/s41440-025-02222-y

Published Online: 2025-05-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark